Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1731 News Items found MSK Scientists Identify New — and Very Common — Subtype of Prostate Cancer Friday, May 27, 2022 The findings could pave the way toward more targeted treatments for the disease. Recognizing AANHPI Heritage Month: How To Train Your (MSK) Dragons Monday, May 23, 2022 You sometimes hear the steady beat of the drum before you see the boat. An imposing figure then comes into view, slicing through the water. It’s a m... How People With Cancer Can Decrease Food Poisoning Risk Monday, May 23, 2022 Learn how people with cancer can protect themselves against foodborne illness. Event MSK’s 2022 Convocation and Commencement Ceremony Recognizes Graduates and Award Winners Friday, May 20, 2022 At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event. Tomya Watt Receives Mentor Award From ‘Moves’ Magazine Friday, May 20, 2022 Tomya Watt, Chief Diversity Officer and Vice President of Talent Acquisition and Mobility, was selected to receive the 2022 Moves Mentor Award from ’Moves‘ Magazine. Finding A Warning Against Using Phone Apps To Detect Skin Cancer Thursday, May 19, 2022 Despite the promise of eventually using artificial intelligence to detect melanoma, much more research and development are needed, MSK experts find. Picking the Winners: Study Sheds Light on Possible Best Targets for Pancreatic Cancer Vaccine Thursday, May 19, 2022 Research confirms a sound strategy for designing a therapeutic vaccine for pancreatic cancer. New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer Wednesday, May 18, 2022 By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults. Richard Gilbertson Named 2022 Society of Memorial Sloan Kettering Prize Recipient for Contributions in Pediatric Oncology Wednesday, May 18, 2022 Memorial Sloan Kettering Cancer Center (MSK) announced that pediatric oncologist Richard Gilbertson, MBBS, PhD, of Cancer Research UK Cambridge Institute, has been named the 2022 recipient of The Society of Memorial Sloan Kettering Prize. Mary Wu: A Champion for Life Tuesday, May 17, 2022 Meet Mary Wu, a patient financial services specialist at Memorial Sloan Kettering Westchester. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer